Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Array Biopharma Inc (ARRY) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Array Biopharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1100412.
Total stock buying since 2015: $23,511,300.
Total stock sales since 2015: $75,980,858.
Total stock option exercises since 2015: $21,241,924.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 5,000 | $116,000 | 1,237,051 | $27,126,433 | 1,265,777 | $6,098,440 |
| 2018 | 3,000 | $50,594 | 990,562 | $16,806,978 | 1,297,732 | $4,291,416 |
| 2017 | 0 | $0 | 1,251,338 | $13,541,812 | 1,611,054 | $8,186,685 |
| 2016 | 1,700,000 | $6,025,220 | 2,892,578 | $17,253,088 | 120,890 | $499,584 |
| 2015 | 3,203,985 | $17,319,486 | 156,576 | $1,252,547 | 364,093 | $2,165,799 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-06 | 0 | $0 | 136,134 | $3,847,756 | 136,134 | $861,889 |
| 2019-05 | 0 | $0 | 143,877 | $3,866,190 | 115,728 | $422,406 |
| 2019-04 | 0 | $0 | 0 | $0 | 86,877 | $0 |
| 2019-02 | 5,000 | $116,000 | 708,602 | $14,854,352 | 572,264 | $2,812,925 |
| 2019-01 | 0 | $0 | 248,438 | $4,558,135 | 354,774 | $2,001,220 |
| 2018-12 | 0 | $0 | 121,453 | $1,955,123 | 257,087 | $464,999 |
| 2018-11 | 3,000 | $50,594 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2018-09 | 0 | $0 | 27,687 | $414,617 | 18,000 | $107,100 |
| 2018-08 | 0 | $0 | 41,500 | $577,680 | 21,500 | $124,162 |
| 2018-07 | 0 | $0 | 96,500 | $1,600,290 | 123,025 | $586,596 |
| 2018-06 | 0 | $0 | 323,717 | $5,900,039 | 400,967 | $1,427,349 |
| 2018-05 | 0 | $0 | 21,500 | $330,261 | 21,500 | $88,472 |
| 2018-04 | 0 | $0 | 30,189 | $459,961 | 64,937 | $79,335 |
| 2018-03 | 0 | $0 | 177,516 | $3,123,383 | 203,691 | $738,957 |
| 2018-02 | 0 | $0 | 121,500 | $2,064,439 | 121,500 | $576,422 |
| 2018-01 | 0 | $0 | 29,000 | $381,185 | 35,525 | $98,024 |
| 2017-12 | 0 | $0 | 1,102,545 | $11,936,724 | 1,355,900 | $6,619,460 |
| 2017-10 | 0 | $0 | 0 | $0 | 25,000 | $261,750 |
| 2017-09 | 0 | $0 | 78,793 | $971,938 | 90,000 | $952,200 |
| 2017-08 | 0 | $0 | 0 | $0 | 20,000 | $75,400 |
| 2017-04 | 0 | $0 | 0 | $0 | 50,154 | $0 |
| 2017-03 | 0 | $0 | 70,000 | $633,150 | 70,000 | $277,875 |
| 2016-10 | 0 | $0 | 0 | $0 | 25,000 | $145,750 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-04 | Sandor Victor (Chief Medical Officer) | Sale | 100,000 | 28.51 | 2,851,000 |
| 2019-06-04 | Sandor Victor (Chief Medical Officer) | Option Ex | 100,000 | 7.30 | 730,000 |
| 2019-06-03 | Sandor Victor (Chief Medical Officer) | Sale | 36,134 | 27.59 | 996,756 |
| 2019-06-03 | Sandor Victor (Chief Medical Officer) | Option Ex | 36,134 | 3.65 | 131,889 |
| 2019-05-30 | Sandor Victor (Chief Medical Officer) | Sale | 15,728 | 27.50 | 432,520 |
| 2019-05-30 | Sandor Victor (Chief Medical Officer) | Option Ex | 15,728 | 3.65 | 57,407 |
| 2019-05-28 | Sandor Victor (Chief Medical Officer) | Sale | 74,915 | 27.00 | 2,022,929 |
| 2019-05-28 | Sandor Victor (Chief Medical Officer) | Option Ex | 46,766 | 3.65 | 170,695 |
| 2019-05-23 | Sandor Victor (Chief Medical Officer) | Sale | 40,634 | 26.50 | 1,076,841 |
| 2019-05-23 | Sandor Victor (Chief Medical Officer) | Option Ex | 40,634 | 3.65 | 148,314 |
| 2019-05-21 | Sandor Victor (Chief Medical Officer) | Sale | 12,600 | 26.50 | 333,900 |
| 2019-05-21 | Sandor Victor (Chief Medical Officer) | Option Ex | 12,600 | 3.65 | 45,990 |
| 2019-04-01 | Sandor Victor (Chief Medical Officer) | Option Ex | 15,626 | .00 | 0 |
| 2019-04-01 | Saccomano Nicholas A (CSO) | Option Ex | 13,750 | .00 | 0 |
| 2019-04-01 | Robbins Andrew R (COO) | Option Ex | 19,688 | .00 | 0 |
| 2019-04-01 | Squarer Ron (CEO) | Option Ex | 37,813 | .00 | 0 |
| 2019-02-19 | Cox Carrie Smith | Buy | 5,000 | 23.20 | 116,000 |
| 2019-02-07 | Haddock Jason (CFO) | Sale | 85,000 | 22.05 | 1,874,334 |
| 2019-02-07 | Haddock Jason (CFO) | Option Ex | 85,000 | 3.77 | 320,450 |
| 2019-02-07 | Saccomano Nicholas A (CSO) | Sale | 187,264 | 21.58 | 4,041,718 |
| 2019-02-07 | Saccomano Nicholas A (CSO) | Option Ex | 187,264 | 3.60 | 674,150 |
| 2019-02-07 | Squarer Ron (CEO) | Sale | 110,000 | 21.64 | 2,380,070 |
| 2019-02-07 | Squarer Ron (CEO) | Option Ex | 110,000 | 3.61 | 397,100 |
| 2019-02-06 | Haddock Jason (CFO) | Sale | 11,712 | 20.00 | 234,240 |
| 2019-02-06 | Robbins Andrew R (COO) | Sale | 239,626 | 20.02 | 4,798,510 |
| 2019-02-06 | Robbins Andrew R (COO) | Option Ex | 125,000 | 6.42 | 801,875 |
| 2019-02-06 | Lefkoff Kyle | Sale | 35,000 | 20.73 | 725,480 |
| 2019-02-06 | Lefkoff Kyle | Option Ex | 25,000 | 10.47 | 261,750 |
| 2019-02-05 | Oltmans Curtis Gale (General Counsel) | Sale | 40,000 | 20.00 | 800,000 |
| 2019-02-05 | Oltmans Curtis Gale (General Counsel) | Option Ex | 40,000 | 8.94 | 357,600 |
| 2019-01-31 | Saccomano Nicholas A (CSO) | Option Ex | 95,236 | 4.20 | 399,991 |
| 2019-01-31 | Squarer Ron (CEO) | Sale | 113,438 | 18.53 | 2,101,552 |
| 2019-01-31 | Squarer Ron (CEO) | Option Ex | 113,438 | 7.30 | 828,097 |
| 2019-01-30 | Squarer Ron (CEO) | Sale | 100,000 | 18.25 | 1,825,400 |
| 2019-01-30 | Squarer Ron (CEO) | Option Ex | 100,000 | 3.61 | 361,000 |
| 2019-01-29 | Oltmans Curtis Gale (General Counsel) | Option Ex | 11,100 | 8.94 | 99,234 |
| 2019-01-25 | Oltmans Curtis Gale (General Counsel) | Sale | 14,029 | 18.00 | 252,522 |
| 2019-01-25 | Oltmans Curtis Gale (General Counsel) | Option Ex | 14,029 | 8.94 | 125,419 |
| 2019-01-18 | Oltmans Curtis Gale (General Counsel) | Sale | 1,251 | 18.00 | 22,518 |
| 2019-01-18 | Oltmans Curtis Gale (General Counsel) | Option Ex | 1,251 | 8.94 | 11,183 |
| 2019-01-15 | Oltmans Curtis Gale (General Counsel) | Sale | 19,720 | 18.06 | 356,143 |
| 2019-01-15 | Oltmans Curtis Gale (General Counsel) | Option Ex | 19,720 | 8.94 | 176,296 |
| 2018-12-27 | Sandor Victor (Chief Medical Officer) | Sale | 6,268 | 14.05 | 88,090 |
| 2018-12-16 | Oltmans Curtis Gale (General Counsel) | Option Ex | 7,000 | .00 | 0 |
| 2018-12-16 | Haddock Jason (CFO) | Option Ex | 11,387 | .00 | 0 |
| 2018-12-16 | Sandor Victor (Chief Medical Officer) | Option Ex | 23,346 | .00 | 0 |
| 2018-12-16 | Saccomano Nicholas A (CSO) | Option Ex | 12,469 | .00 | 0 |
| 2018-12-16 | Robbins Andrew R (COO) | Option Ex | 27,051 | .00 | 0 |
| 2018-12-16 | Squarer Ron (CEO) | Option Ex | 48,437 | .00 | 0 |
| 2018-12-03 | Sandor Victor (Chief Medical Officer) | Sale | 115,185 | 16.21 | 1,867,033 |
| 2018-12-03 | Sandor Victor (Chief Medical Officer) | Option Ex | 127,397 | 3.65 | 464,999 |
| 2018-11-01 | Cox Carrie Smith | Buy | 3,000 | 16.86 | 50,594 |
| 2018-10-26 | Baum Charles M | Option Ex | 5,000 | .00 | 0 |
| 2018-10-26 | Fyfe Gwen A. | Option Ex | 5,000 | .00 | 0 |
| 2018-10-26 | Orwin John A | Option Ex | 5,000 | .00 | 0 |
| 2018-10-26 | Sharp Shalini | Option Ex | 5,000 | .00 | 0 |
| 2018-10-26 | Van Lunsen Gil J | Option Ex | 5,000 | .00 | 0 |
| 2018-10-26 | Lefkoff Kyle | Option Ex | 5,000 | .00 | 0 |
| 2018-09-19 | Van Lunsen Gil J | Sale | 18,000 | 14.76 | 265,680 |
| 2018-09-19 | Van Lunsen Gil J | Option Ex | 18,000 | 5.95 | 107,100 |
| 2018-09-04 | Sandor Victor (Chief Medical Officer) | Sale | 9,687 | 15.38 | 148,937 |
| 2018-08-15 | Haddock Jason (CFO) | Sale | 20,000 | 13.92 | 278,400 |
| 2018-08-15 | Van Lunsen Gil J | Sale | 21,500 | 13.92 | 299,280 |
| 2018-08-15 | Van Lunsen Gil J | Option Ex | 21,500 | 5.78 | 124,162 |
| 2018-07-30 | Haddock Jason (CFO) | Sale | 25,000 | 14.87 | 371,750 |
| 2018-07-30 | Haddock Jason (CFO) | Option Ex | 51,525 | 3.77 | 194,249 |
| 2018-07-18 | Van Lunsen Gil J | Sale | 21,500 | 16.56 | 356,040 |
| 2018-07-18 | Van Lunsen Gil J | Option Ex | 21,500 | 5.37 | 115,347 |
| 2018-07-06 | Lefkoff Kyle (Director) | Sale | 50,000 | 17.45 | 872,500 |
| 2018-07-06 | Lefkoff Kyle (Director) | Option Ex | 50,000 | 5.54 | 277,000 |
| 2018-06-27 | Sandor Victor (Chief Medical Officer) | Option Ex | 17,440 | .00 | 0 |
| 2018-06-27 | Saccomano Nicholas A (CSO) | Option Ex | 11,453 | .00 | 0 |
| 2018-06-27 | Robbins Andrew R (COO) | Sale | 17,964 | 17.74 | 318,681 |
| 2018-06-27 | Robbins Andrew R (COO) | Option Ex | 32,068 | .00 | 0 |
| 2018-06-27 | Squarer Ron (CEO) | Sale | 184,253 | 17.89 | 3,295,364 |
| 2018-06-27 | Squarer Ron (CEO) | Option Ex | 218,506 | 4.39 | 960,333 |
| 2018-06-20 | Van Lunsen Gil J | Sale | 21,500 | 19.08 | 410,219 |
| 2018-06-20 | Van Lunsen Gil J | Option Ex | 21,500 | 4.75 | 102,017 |
| 2018-06-19 | Sandor Victor (Chief Medical Officer) | Sale | 77,576 | 18.76 | 1,455,325 |
| 2018-06-19 | Sandor Victor (Chief Medical Officer) | Option Ex | 77,576 | 3.65 | 283,152 |
| 2018-06-13 | Sandor Victor (Chief Medical Officer) | Sale | 22,424 | 18.75 | 420,450 |
| 2018-06-13 | Sandor Victor (Chief Medical Officer) | Option Ex | 22,424 | 3.65 | 81,847 |
| 2018-05-16 | Van Lunsen Gil J (Director) | Sale | 21,500 | 15.36 | 330,261 |
| 2018-05-16 | Van Lunsen Gil J (Director) | Option Ex | 21,500 | 4.12 | 88,472 |
| 2018-04-18 | Van Lunsen Gil J | Sale | 21,500 | 15.19 | 326,585 |
| 2018-04-18 | Van Lunsen Gil J | Option Ex | 21,500 | 3.69 | 79,335 |
| 2018-04-03 | Sandor Victor (Chief Medical Officer) | Sale | 8,689 | 15.35 | 133,376 |
| 2018-04-01 | Sandor Victor (Chief Medical Officer) | Option Ex | 7,812 | .00 | 0 |
| 2018-04-01 | Saccomano Nicholas A (CSO) | Option Ex | 6,875 | .00 | 0 |
| 2018-04-01 | Robbins Andrew R (COO) | Option Ex | 9,844 | .00 | 0 |
| 2018-04-01 | Squarer Ron (CEO) | Option Ex | 18,906 | .00 | 0 |
| 2018-03-21 | Van Lunsen Gil J | Sale | 21,500 | 16.76 | 360,340 |
| 2018-03-21 | Van Lunsen Gil J | Option Ex | 21,500 | 3.44 | 73,960 |
| 2018-03-09 | Sandor Victor (Chief Medical Officer) | Sale | 156,016 | 17.71 | 2,763,043 |
| 2018-03-09 | Sandor Victor (Chief Medical Officer) | Option Ex | 182,191 | 3.65 | 664,997 |
| 2018-02-21 | Van Lunsen Gil J | Sale | 21,500 | 17.16 | 368,940 |
| 2018-02-21 | Van Lunsen Gil J | Option Ex | 21,500 | 2.92 | 62,672 |
| 2018-02-09 | Baum Charles M | Sale | 50,000 | 16.90 | 844,999 |
| 2018-02-09 | Baum Charles M | Option Ex | 50,000 | 5.54 | 277,000 |
| 2018-02-09 | Lefkoff Kyle | Sale | 50,000 | 17.01 | 850,500 |
| 2018-02-09 | Lefkoff Kyle | Option Ex | 50,000 | 4.74 | 236,750 |
| 2018-01-17 | Van Lunsen Gil J | Sale | 21,500 | 12.94 | 278,210 |
| 2018-01-17 | Van Lunsen Gil J | Option Ex | 21,500 | 2.10 | 45,150 |
| 2018-01-16 | Haddock Jason (CFO) | Sale | 7,500 | 13.73 | 102,975 |
| 2018-01-16 | Haddock Jason (CFO) | Option Ex | 14,025 | 3.77 | 52,874 |
| 2017-12-19 | Squarer Ron (CEO) | Sale | 546,233 | 10.93 | 5,970,326 |
| 2017-12-19 | Squarer Ron (CEO) | Option Ex | 546,233 | 4.73 | 2,582,043 |
| 2017-12-18 | Robbins Andrew R (COO) | Sale | 282,874 | 10.72 | 3,032,409 |
| 2017-12-18 | Robbins Andrew R (COO) | Option Ex | 397,500 | 4.90 | 1,946,954 |
| 2017-12-18 | Squarer Ron (CEO) | Sale | 273,438 | 10.73 | 2,933,989 |
| 2017-12-18 | Squarer Ron (CEO) | Option Ex | 354,509 | 5.62 | 1,991,277 |
| 2017-12-16 | Haddock Jason (CFO) | Option Ex | 4,387 | .00 | 0 |
| 2017-12-16 | Sandor Victor (Chief Medical Officer) | Option Ex | 11,284 | 8.79 | 99,186 |
| 2017-12-16 | Saccomano Nicholas A (CSO) | Option Ex | 5,468 | .00 | 0 |
| 2017-12-16 | Robbins Andrew R (COO) | Option Ex | 13,082 | .00 | 0 |
| 2017-12-16 | Squarer Ron (CEO) | Option Ex | 23,437 | .00 | 0 |
| 2017-10-27 | Baum Charles M | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-10-27 | Fyfe Gwen A. | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-10-27 | Orwin John A | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-10-27 | Van Lunsen Gil J | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-10-27 | Lefkoff Kyle | Option Ex | 5,000 | 10.47 | 52,350 |
| 2017-09-29 | Van Lunsen Gil J | Sale | 39,928 | 12.36 | 493,510 |
| 2017-09-29 | Van Lunsen Gil J | Option Ex | 45,000 | 10.58 | 476,100 |
| 2017-09-29 | Lefkoff Kyle | Sale | 38,865 | 12.31 | 478,428 |
| 2017-09-29 | Lefkoff Kyle | Option Ex | 45,000 | 10.58 | 476,100 |
| 2017-08-14 | Haddock Jason (CFO) | Option Ex | 20,000 | 3.77 | 75,400 |
| 2017-04-01 | Sandor Victor (Chief Medical Officer) | Option Ex | 7,812 | .00 | 0 |
| 2017-04-01 | Saccomano Nicholas A (CSO) | Option Ex | 6,875 | .00 | 0 |
| 2017-04-01 | Robbins Andrew R (COO) | Option Ex | 9,843 | .00 | 0 |
| 2017-04-01 | Squarer Ron (CEO) | Option Ex | 18,906 | .00 | 0 |
| 2017-04-01 | Moore John R (VP, General Counsel) | Option Ex | 6,718 | .00 | 0 |
| 2017-03-31 | Lefkoff Kyle | Sale | 45,000 | 8.92 | 401,400 |
| 2017-03-31 | Lefkoff Kyle | Option Ex | 45,000 | 4.03 | 181,125 |
| 2017-03-28 | Baum Charles M | Sale | 25,000 | 9.27 | 231,750 |
| 2017-03-28 | Baum Charles M | Option Ex | 25,000 | 3.87 | 96,750 |
| 2016-10-29 | Baum Charles M | Option Ex | 5,000 | 5.83 | 29,150 |
| 2016-10-29 | Fyfe Gwen A. | Option Ex | 5,000 | 5.83 | 29,150 |
| 2016-10-29 | Orwin John A | Option Ex | 5,000 | 5.83 | 29,150 |
| 2016-10-29 | Van Lunsen Gil J | Option Ex | 5,000 | 5.83 | 29,150 |
| 2016-10-29 | Lefkoff Kyle | Option Ex | 5,000 | 5.83 | 29,150 |
| 2016-09-28 | Green Jeremy | Sale | 2,492,578 | 6.36 | 15,852,796 |
| 2016-09-22 | Sandor Victor (Chief Medical Officer) | Option Ex | 95,890 | 3.69 | 353,834 |
| 2016-09-15 | Green Jeremy | Buy | 28,000 | 3.50 | 98,000 |
| 2016-09-15 | Green Jeremy | Sale | 7,300 | 3.54 | 25,842 |
| 2016-09-14 | Green Jeremy | Buy | 372,000 | 3.51 | 1,305,720 |
| 2016-09-14 | Green Jeremy | Sale | 392,700 | 3.50 | 1,374,450 |
| 2016-01-20 | Green Jeremy | Buy | 300,000 | 3.19 | 957,000 |
| 2016-01-12 | Green Jeremy | Buy | 75,000 | 3.60 | 270,000 |
| 2016-01-11 | Green Jeremy | Buy | 275,000 | 3.54 | 973,500 |
| 2016-01-08 | Green Jeremy | Buy | 350,000 | 3.72 | 1,302,000 |
| 2016-01-07 | Green Jeremy | Buy | 300,000 | 3.73 | 1,119,000 |
| 2015-10-01 | Green Jeremy | Buy | 100,140 | 4.50 | 450,630 |
| 2015-09-30 | Green Jeremy | Buy | 182,452 | 4.67 | 852,050 |
| 2015-09-29 | Green Jeremy | Buy | 500,000 | 4.56 | 2,280,000 |
| 2015-09-22 | Sandor Victor (Chief Medical Officer) | Option Ex | 95,891 | 5.18 | 496,715 |
| 2015-08-26 | Green Jeremy | Buy | 49,900 | 5.48 | 273,452 |
| 2015-08-25 | Green Jeremy | Buy | 220,000 | 5.45 | 1,199,000 |
| 2015-08-24 | Green Jeremy | Buy | 410,000 | 5.32 | 2,181,200 |
| 2015-08-21 | Green Jeremy | Buy | 160,000 | 5.45 | 872,000 |
| 2015-08-12 | Green Jeremy | Buy | 205,000 | 5.93 | 1,215,650 |
| 2015-08-11 | Green Jeremy | Buy | 327,500 | 5.85 | 1,915,875 |
| 2015-08-10 | Green Jeremy | Buy | 180,000 | 5.81 | 1,045,799 |
| 2015-08-07 | Green Jeremy | Buy | 276,543 | 5.67 | 1,567,998 |
| 2015-08-06 | Green Jeremy | Buy | 592,450 | 5.85 | 3,465,832 |
| 2015-05-08 | Baum Charles M (Director) | Sale | 25,000 | 7.38 | 184,475 |
| 2015-05-08 | Baum Charles M (Director) | Option Ex | 25,000 | 3.86 | 96,500 |
| 2015-03-03 | Lefkoff Kyle (Director) | Sale | 70,000 | 8.00 | 560,070 |
| 2015-03-03 | Lefkoff Kyle (Director) | Option Ex | 70,000 | 2.77 | 193,900 |
| 2015-03-02 | Robbins Andrews R (SVP, Commercial Operations) | Sale | 21,576 | 8.25 | 178,002 |
| 2015-03-02 | Squarer Ron (CEO) | Sale | 40,000 | 8.25 | 330,000 |
| 2015-03-01 | Sandor Victor (Chief Medical Officer.) | Option Ex | 17,440 | 7.96 | 138,822 |
| 2015-03-01 | Saccomano Nicholas A (CSO) | Option Ex | 11,453 | 7.96 | 91,165 |
| 2015-03-01 | Robbins Andrews R (SVP, Commercial Operations) | Option Ex | 32,069 | 7.96 | 255,269 |
| 2015-03-01 | Squarer Ron (CEO) | Option Ex | 77,881 | 7.96 | 619,932 |
| 2015-03-01 | Moore John R (VP, General Counsel) | Option Ex | 22,906 | 7.96 | 182,331 |
| 2015-03-01 | Snitman David (COO and VP, Business Devel.) | Option Ex | 11,453 | 7.96 | 91,165 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARRY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Array Biopharma Inc (symbol ARRY, CIK number 1100412) see the Securities and Exchange Commission (SEC) website.